Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

KMS MEDISURGI LTD.

NSE : NABSE : 540468ISIN CODE : INE870V01014Industry : Medical Equipment/Supplies/AccessoriesHouse : Private

BSE126.506 (+4.98 %)

PREV CLOSE ( ) 120.50

OPEN PRICE ( ) 126.50

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1000

TODAY'S LOW / HIGH ( )126.50 126.50

52 WK LOW / HIGH ( ) 120.5132.3

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 25-03 1999

Management Info

Siddharth Kanakia - Chairman Siddharth Kanakia - Managing Director

Registered Office

Address 297/301 May Building, Ground Floor,Princess Street,Marine Lines (East),
Mumbai,
Maharashtra-400002

Phone 022-66107700 / 22 / 67498822

Email info@kmsgroup.in

Website www.kmsgroup.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE

NEWS

15Jul KMS Medisurgi informs about compliance
Pursuant to Regulations 74(5) of SEBI (Depositories and Participants) Re..

15Jul KMS Medisurgi informs about non-applic
KMS Medisurgi has informed that as per Regulation 15(2) of SEBI (Listing..

20Jun KMS Medisurgi informs about board meet
KMS Medisurgi has informed that the Meeting of the Board of Directors of..

20Jun Appointment of Director
Interalia, to discuss, consider and approve the appointment of Ms. Pooja..

06May KMS Medisurgi informs about book closure
Pursuant to section 91 of the Companies Act, 2013 and Regulation 42 of t..

Financials

Rs. in Millions

	QTR	ANNUAL 25
Net Profit		4.37999999999998
Gross Profit		6.08999999999998
Operating Profit		9.57999999999998
Net Sales		139.39

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Centenial Surgical (BSE) 158.45 (1.57%)	M.Cap ( in Cr)57.81
Raaj Medisafe India (BSE) 100.00 (0.57%)	M.Cap ( in Cr)132.13
Laser Eyecare (BSE) 6.97 (1.90%)	M.Cap ( in Cr)4.88
Kretto Syscon (BSE) 2.00 (-0.50%)	M.Cap ( in Cr)125.44
GKB Ophthalmics (BSE) 74.02 (-2.61%)	M.Cap ( in Cr)37.31

Shareholding Pattern

	PROMOTERS	74.42%
	NON-INSTITUTION	25.58%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

KMS MEDISURGI LTD.